These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20214477)

  • 21. Issues in the management of HIV-related tuberculosis.
    Burman WJ
    Clin Chest Med; 2005 Jun; 26(2):283-94, vi-vii. PubMed ID: 15837111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of antituberculosis treatment on virological response to highly active antiretroviral therapy: implications for resource-limited settings?
    Lawn SD; Wood R
    J Infect Dis; 2006 Nov; 194(10):1467-8; author reply 1468. PubMed ID: 17054078
    [No Abstract]   [Full Text] [Related]  

  • 23. Ritonavir promotes increased growth in HIV-infected children. Paediatric AIDS Group of Switzerland.
    Nadal D; Steiner F; Cheseaux JJ; Rudin C
    AIDS; 1998 Dec; 12(17):2356-7. PubMed ID: 9863884
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact of a public antiretroviral program on TB/HIV mortality: Banteay Meanchey, Cambodia.
    Eng B; Cain KP; Nong K; Chhum V; Sin E; Roeun S; Kim S; Keo S; Heller TA; Varma JK
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):89-92. PubMed ID: 19323039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.
    Ribera E; Azuaje C; Lopez RM; Domingo P; Curran A; Feijoo M; Pou L; Sánchez P; Sambeat MA; Colomer J; Lopez-Colomes JL; Crespo M; Falcó V; Ocaña I; Pahissa A
    J Antimicrob Chemother; 2007 Apr; 59(4):690-7. PubMed ID: 17307771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxicity of first-line drugs for treatment of tuberculosis in children: review.
    Frydenberg AR; Graham SM
    Trop Med Int Health; 2009 Nov; 14(11):1329-37. PubMed ID: 19735381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement in CD 4 counts in HIV positive patients treated with HAART and antitubercular drugs: an observational study from North India.
    Sharma A; Wanchu A; Bansal V; Singh S; Varma S
    Indian J Pathol Microbiol; 2007 Oct; 50(4):905-7. PubMed ID: 18306602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early diagnosis of tuberculosis using an INF-gamma assay in a child with HIV-1 infection and a very low CD4 count.
    Spyridis N; Chakraborty R; Sharland M; Heath PT
    Scand J Infect Dis; 2007; 39(10):919-21. PubMed ID: 17852915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and 48 week efficacy of low-dose lopinavir/ritonavir in HIV-infected children.
    Puthanakit T; van der Lugt J; Bunupuradah T; Ananworanich J; Gorowara M; Phasomsap C; Jupimai T; Boonrak P; Pancharoen C; Burger D; Ruxrungtham K
    J Antimicrob Chemother; 2009 Nov; 64(5):1080-6. PubMed ID: 19729375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First-line antiretroviral therapy in resource-limited settings: time to reconsider?
    Adlington R; Richens J; Shahmanesh M
    J Infect Dis; 2009 May; 199(9):1407; author reply 1407-8. PubMed ID: 19358673
    [No Abstract]   [Full Text] [Related]  

  • 31. [Tuberculosis and AIDS in Pediatrics: on account of five cases].
    Villarroel J; Vizueta E; Alvarez AM; Galaz MI; Peña A; Schuffeneger P; Chávez A
    Rev Chilena Infectol; 2007 Dec; 24(6):472-6. PubMed ID: 18180822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of rifabutin with protease inhibitors for human immunodeficiency virus-infected patients with tuberculosis.
    Narita M; Stambaugh JJ; Hollender ES; Jones D; Pitchenik AE; Ashkin D
    Clin Infect Dis; 2000 May; 30(5):779-83. PubMed ID: 10816148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on antiretroviral therapy in paediatrics.
    Penazzato M; Donà D; Wool PS; Rampon O; Giaquinto C
    Antiviral Res; 2010 Jan; 85(1):266-75. PubMed ID: 19879898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-drug interactions and tolerance in combining antituberculosis and antiretroviral therapy.
    Di Perri G; Aguilar Marucco D; Mondo A; Gonzalez de Requena D; Audagnotto S; Gobbi F; Bonora S
    Expert Opin Drug Saf; 2005 Sep; 4(5):821-36. PubMed ID: 16111446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tuberculosis in HIV-infected patients: a comprehensive review.
    Aaron L; Saadoun D; Calatroni I; Launay O; Mémain N; Vincent V; Marchal G; Dupont B; Bouchaud O; Valeyre D; Lortholary O
    Clin Microbiol Infect; 2004 May; 10(5):388-98. PubMed ID: 15113314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly active antiretroviral therapy (HAART) in adults with tuberculosis: current status.
    Kwara A; Flanigan TP; Carter EJ
    Int J Tuberc Lung Dis; 2005 Mar; 9(3):248-57. PubMed ID: 15786886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus.
    Nguyen ST; Eaton SA; Bain AM; Rahman AP; Payne KD; Bedimo R; Herrington JD; Maclayton DO; Rodriguez-Barradas MC; Busti AJ
    Pharmacotherapy; 2008 Mar; 28(3):323-30. PubMed ID: 18294112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tuberculosis and tuberculosis/HIV co-infection in pregnancy.
    Adhikari M
    Semin Fetal Neonatal Med; 2009 Aug; 14(4):234-40. PubMed ID: 19303830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.
    Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW
    Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Remission of HIV-associated myelopathy after highly active antiretroviral therapy.
    Fernández-Fernández FJ; de la Fuente-Aguado J; Ocampo-Hermida A; Iglesias-Castañón A
    J Postgrad Med; 2004; 50(3):195-6. PubMed ID: 15377804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.